|
Singapore medical company can diagnose H1N1 in 2 hours
SINGAPORE, Jul 06, 2009 (Xinhua via COMTEX) --
A Singapore medical diagnostics
company has announced on Monday that a chip it produced has tested
successfully on confirmed pandemic H1N1-2009 influenza positive
samples.
VereFlu influenza chip is developed by Veredus Laboratories, a
local medical diagnostics company in conjunction with ST
Microelectronics, a global leader in silicon chip design and
manufacturing, according to a statement issued by Veredus
Laboratories on Monday.
The VereFlu chip is a portable lab-on-chip application that can
identify and differentiate human strains of Influenza A and B
viruses in a single test with high accuracy and sensitivity.
It is a portable lab-on-chip application for rapid detection of
all major influenza types at the point of need in a single test.
Unlike existing diagnostic methods, VereFlu can detect infection
with high accuracy and sensitivity within two hours, providing
genetic information of the infection that traditionally would take
days to weeks to learn.
The chip has been tested successfully in a joint trial with the
Singapore Health Ministry's National Public Health Laboratory (
NPHL).
The ability of the chip to simultaneously lock on multiple
segments of the genes of the H1N1 influenza virus enables it to
identify the virus with a much higher degree of confidence
compared to other tests.
Rosemary Tan, Chief Executive Officer of Veredus Laboratories,
said that its next step is to enable the chip to check for drug
resistance in Influenza A (H1N1) as it mutates. This will
significantly enhance its capability to combat potentially deadly
variants of influenza viruses.
VereFlu is already being deployed to several pilot users in
Asia and Middle East.
Singapore reported its first confirmed case of Influenza A/H1N1
on May 27, and the country has a total number of such cases to
1055 so far.
[ Back To TMCnet.com's Homepage ]
|